title: [Hemorheological disorders in Epstein-Barr virus mononucleosis in children and methods of their correction].
abstract: The results of observations in a group of 80 young patients aged 1-14 years with diagnosis of primary Epstein-Barr virus (EBV) infection are presented. Hemorheological disorders arising from the EBV mononucleosis were identified. The results of using reamberin in the infusion therapy for the correction of hemorheological disorders have been analyzed. It is established that reamberine infusion reduces the plasma viscosity and blood viscosity, rapidly improves the condition of children, and restores hemodynamic indices. The use of reamberine helped to reduce the duration of hospital treatment for patients with severe EBV mononucleosis.
authors.forename: N M
authors.initials: NM
authors.lastname: Shvedova
authors.forename: E V
authors.initials: EV
authors.lastname: Mikhaĭlova
mesh_terms: D000293:Adolescent; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D005260:Female; D018056:Hemorheology / Q000187:drug effects*; D006801:Humans; D007223:Infant; D007244:Infectious Mononucleosis / Q000097:blood / Q000188:drug therapy; D008297:Male; D008536:Meglumine / Q000031:analogs & derivatives* / Q000494:pharmacology; D013386:Succinates / Q000494:pharmacology*
chemical_list: C549374:Reamberin; D013386:Succinates; D008536:Meglumine